Drug Overdoses Hit a Record High in 2017

Fentanyl and other synthetic opioids are driving the increase.

Kelli Lane and Mary Randol grieve the loss of Randol's son, Dustin Billings, to an overdose in Indiana.Don Knight/The Herald-Bulletin/AP

The number of deaths from drug overdoses reached a record high of 72,000 in 2017, a 10 percent rise from the previous year, according to new provisional estimates form the Centers for Disease Control and Prevention.


The increase was driven by the prevalence of fentanyl and other potent synthetic opioids, which were involved in roughly 30,000 overdoses overdose deaths. (That number is likely an underestimate given the regional differences in how drug deaths are reported.)

The epidemic has put strain on virtually every sphere of the public sector, including police departments, coroner’s offices, public health agencies, and foster care systems. States are tapping into the $1 billion in federal funding available for prevention and treatment, but many say that that there’s not nearly enough money to address a crisis that costs hundreds of billions of dollars annually.

My heart sank to see the huge percentage rises in hard-hit states like Ohio and West Virginia,” said Keith Humphreys, a Stanford psychiatry professor who advised Presidents Bush and Obama on drug policy. “That region already had such high overdose rates that it takes many more additional deaths to make them rise than it would for a state with a lower base.”

However, drug policy experts are cautiously optimistic about some of the new numbers. Though overdose deaths jumped, they rose more slowly than in previous years. (Between 2015 and 2016, there was a roughly 20 percent rise in overdoses.) And in some states, the number of overdoses fell—including Massachusetts, which has long been hit hard by the scourge of heroin and fentanyl. The slowing of deaths in Massachusetts may be due to the state’s multi-pronged response: It has poured resources into increasing access to evidence-based treatment and overdose reversal drug naloxone, as well as restricting the opioids in circulation. But because the country lacks accurate data on the number of Americans addicted to opioids, it’s difficult to know which strategies are working, notes Dr. Dan Ciccarone, an epidemiologist at University of California-San Francisco. 

Ciccarone suspects that the epidemic will slowly level off and decrease over time. “I don’t think we’re going to see a rapid turnaround, because we haven’t—certainly not centrally or nationally—done enough,” he says. “We’re still hoping and praying and expecting the federal government to step in because we’re really in need of greater resources in a lot of these poor areas.”

This article has been updated.

OUR NEW CORRUPTION PROJECT

The more we thought about how MoJo's journalism can have the most impact heading into the 2020 election, the more we realized that so many of today's stories come down to corruption: democracy and the rule of law being undermined by the wealthy and powerful for their own gain.

So we're launching a new Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption. We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We'll publish what we find as a major series in the summer of 2020, including a special issue of our magazine, a dedicated online portal, and video and podcast series so it doesn't get lost in the daily deluge of breaking news.

It's unlike anything we've done before and we've got seed funding to get started, but we're asking readers to help crowdfund this new beat with an additional $500,000 so we can go even bigger. You can read why we're taking this approach and what we want to accomplish in "Corruption Isn't Just Another Scandal. It's the Rot Beneath All of Them," and if you like how it sounds, please help fund it with a tax-deductible donation today.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate